Role of Procalcitonin and C-reactive Protein as Marker of Sepsis in Major Burn Patients: A Systematic Review and Meta-analysis
DOI:
https://doi.org/10.3889/oamjms.2021.6137Keywords:
Procalcitonin, C-reactive protein, Major burn, SepsisAbstract
AIM: Although absolute values for C-reactive protein (CRP) and procalcitonin (PCT) are well known to predict sepsis, it remains unclear how their diagnostic value in major burn patients as metabolic changes in burn patient mimic signs and symptoms for sepsis. This paper attempts to clarify these points for both of the markers.
METHODS: A comprehensive literature search of PubMed, Scopus, DOAJ, Web of Science, and the Cochrane Library databases for studies published up to June 1, 2020, that evaluated PCT and/or CRP as a marker for diagnosing sepsis in burn patients was conducted. Review Manager 5.3 was used to analyze the data.
RESULTS: A total of 11 literatures were obtained. The combined sensitivity and specificity for PCT as assessed by meta-analysis were 88% and 89%, respectively. The combined sensitivity and specificity of CRP were described as 85.5% and 57.5%, respectively. Meta-analysis cannot be performed for CRP parameters because there are only two literatures that include CRP diagnostic test values.
DISCUSSION: PCT and CRP have additional diagnostic value for sepsis in patients with major burns. The pooled sensitivity and specificity of PCT are excellent. Although the difference in sensitivity between PCT and CRP is not very large, there are distinct differences in specificity. A low CRP specificity value will show many “false positives” when CRP is used as a biomarker.
CONCLUSION: PCT provides a better diagnostic value than CRP in cases of sepsis in major burn patients. More study on combination of biomarker, clinical presentation, and microbial culture for diagnosing sepsis are needed. Further large-scale research with cohort or case control design should be done.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Greenhalgh DG. Sepsis in the burn patient: A different problem than sepsis in the general population. Burns Trauma. 2017;5:23. https://doi.org/10.1186/s41038-017-0089-5 PMid:28795054 DOI: https://doi.org/10.1186/s41038-017-0089-5
John J, Chisthi MM, Kuttanchettiyar KG. C-reactive protein: An early predictor of sepsis in patients with thermal burns. Int Surg J. 2017;4(2):628-32. https://doi.org/10.18203/2349-2902.isj20170204 DOI: https://doi.org/10.18203/2349-2902.isj20170204
Yan JY, Hill WH, Rehou S, Pinto R, Shahrokhi S, Jeschke MG. Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores. Surgery. 2018;164(6):1241-5. https://doi.org/10.1016/j.surg.2018.05.053 PMid:30049483 DOI: https://doi.org/10.1016/j.surg.2018.05.053
Bloss F, Reinhart K. Rapid diagnosis of sepsis. Virulence. 2014;5(1):154-60. PMid:24335467 DOI: https://doi.org/10.4161/viru.27393
Cabral L, Afreixo V, Almeida L, Paiva JA. The use of procalcitonin (PCT) for diagnosis of sepsis in burn patients: A meta-analysis. PLoS One. 2016;11(12):e0168475. https://doi.org/10.1371/journal.pone.0168475 PMid:28005932 DOI: https://doi.org/10.1371/journal.pone.0168475
Yichao X, Jin X, Shao X, Zheng F, Zhou H. Valuable prognostic indicators for severe burn sepsis with inhalation lesion: Age, platelet count, and procalcitonin. Burns and Trauma. 2018;6:29. https://doi.org/10.1186/s41038-018-0132-1 PMid:30397617 DOI: https://doi.org/10.1186/s41038-018-0132-1
Lavrentieva A, Papadopoulou S, Kioumis J, Kaimakamis E, Bitzani M. PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. Burns. 2012;38(3):356-63. https://doi.org/10.1016/j.burns.2011.08.021 PMid:22037153 DOI: https://doi.org/10.1016/j.burns.2011.08.021
Bargues L, Chancerelle Y, Catineau J, Jault P, Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns. 2007;33(7):860-4. https://doi.org/10.1016/j.burns.2006.10.401 PMid:17532575 DOI: https://doi.org/10.1016/j.burns.2006.10.401
Chivate CG, Belwalkar, Limaye RP, Patil RV. Procalcitonin as a marker for the diagnosis of sepsis. Int J Res Med Sci. 2016;4(4):1216-8. https://doi.org/10.18203/2320-6012.ijrms20160812 DOI: https://doi.org/10.18203/2320-6012.ijrms20160812
Patel DD, Rosenberg M, Rosenberg L, Foncerrada G, Andersen CR, Capek KD, et al. Poverty, population density, and the epidemiology of burns in young children from Mexico treated at a U.S. pediatric burn facility. Burn. 2018;44(5):1269-78. https://doi.org/10.1016/j.burns.2018.02.003 PMid:29551448 DOI: https://doi.org/10.1016/j.burns.2018.02.003
The Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual 2015: The Systematic Review of Studies of Diagnostic Test Accuracy. Australia: The Joanna Briggs Institute; 2015. https://doi.org/10.1111/j.1365-2648.2009.05065.x DOI: https://doi.org/10.1111/j.1365-2648.2009.05065.x
The Joanna Briggs Institute. Critical Appraisal Checklist for Diagnostic Test Accuracy Studies. Australia: The Joanna Briggs Institute; 2017.
Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: A systematic review of the literature. Burns. 2011;37(4):549-58. https://doi.org/10.1016/j.burns.2010.04.013 PMid:20537467 DOI: https://doi.org/10.1016/j.burns.2010.04.013
Pileri D, Accardo-Palumbo A, D’Amelio L, D’Arpa N, Arnone G, Grisaffi C, et al. Serum levels of cortisol, immunoglobulin, and C-reactive protein in burn patients. Ann Burns Fire Disasters. 2009;22(1):3-5. PMid:21991143
Wu CC, Lan HM, Han ST, Chaou CH, Yeh CF, Liu SH, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: A systematic review and meta-analysis. Ann Intensive Care. 2917;7(1):91. https://doi.org/10.1186/s13613-017-0316-z PMid:28875483 DOI: https://doi.org/10.1186/s13613-017-0316-z
Li H, Yao Z, Tan J, Zhou J, Li Y, Wu J, et al. Epidemiology and outcome analysis of 6325 burn patients: A five-year retrospective study in a major burn Center in Southwest China. Sci Rep. 2017;7:46066. https://doi.org/10.1038/srep46066 PMid:28383066 DOI: https://doi.org/10.1038/srep46066
Barati M, Alinejad F, Bahar MA, Tabrisi MS, Shamshiri AR, Bodouhi NO, et al. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns. 2008;34(6):770-4. https://doi.org/10.1016/j.burns.2008.01.014 PMid:18513877 DOI: https://doi.org/10.1016/j.burns.2008.01.014
Madenci ÖC, Yakupoğlu S, Benzonana N, Yücel N, Akbaba D, Kaptanağası AO. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 2014;40(4):664-9. https://doi.org/10.1016/j.burns.2013.08.024 PMid:24074718 DOI: https://doi.org/10.1016/j.burns.2013.08.024
Egea-Guerrero JJ, Martínez-Fernández C, Rodríguez- Rodríguez A, Bohórquez-López A, Vilches-Arenas A, Pacheco- Sánchez M, et al. The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study. Plast Surg (Oakv). 2015;23(4):239-43. https://doi.org/10.1177/229255031502300412 PMid:26665138 DOI: https://doi.org/10.1177/229255031502300412
Sachse C, Machens HG, Felmerer G, Berger A, Henkel E. Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil. 1999;20(5):354-60. https://doi.org/10.1097/00004630-199909000-00004 PMid:10501320 DOI: https://doi.org/10.1097/00004630-199909000-00004
von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin-a sepsis parameter in severe burn injuries. Burns. 1998;24(8):745-50. https://doi.org/10.1016/s0305-4179(98)00109-0 PMid:9915676 DOI: https://doi.org/10.1016/S0305-4179(98)00109-0
Kim HS, Yang HT, Hur J, Chun W, Ju YS, Shin SH, Kang HJ, Lee KM. Procalcitonin levels within 48 hours after burn injury as a prognostic factor. Ann Clin Lab Sci. 2012;42(1):57-64. PMid:22371911
Mokline A, Garsallah L, Rahmani I, Jerbi K, Oueslati H, Tlaili S, Hammouda R, et al. Procalcitonin: A diagnostic and prognostic biomarker of sepsis in burned patients. Ann Burns Fire Disasters. 2015;28(2):116-20. PMid:27252609
Wineberg D, Moore R, Kruger D. Procalcitonin and bacterial sepsis in burn patients in South Africa. J Surg Res. 2020;246:490-8. https://doi.org/10.1016/j.jss.2019.09.040 PMid:31635838 DOI: https://doi.org/10.1016/j.jss.2019.09.040
Seoane L, Pértega S, Galeiras R, Astola I, Bouza T. Procalcitonin in the burn unit and the diagnosis of infection. Burns. 2014;40(2):223-9. https://doi.org/10.1016/j.burns.2013.11.018 PMid:24439927 DOI: https://doi.org/10.1016/j.burns.2013.11.018
Ren H, Li Y, Han C, Hu H. Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: A meta-analysis. Burns. 2015;41(3):502-9. https://doi.org/10.1016/j.burns.2014.08.019 PMid:25648378 DOI: https://doi.org/10.1016/j.burns.2014.08.019
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 A. A. I. Yulan Permatasari, I. G. P. Hendra Sanjaya, I. Gde Raka Widiana, I. Wayan Niryana, A. A. G. Ngurah Asmarajaya, Agus Roy R. H. Hamid, M. Suka Adnyana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0